- Home
- STHO vs NSPR Comparison
STHO vs NSPR Comparison
Compare STHO & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STHO
- NSPR
- Stock Information
- Founded
- STHO N/A
- NSPR 2005
- Country
- STHO United States
- NSPR United States
- Employees
- STHO N/A
- NSPR N/A
- Industry
- STHO Real Estate
- NSPR Medical/Dental Instruments
- Sector
- STHO Real Estate
- NSPR Health Care
- Exchange
- STHO Nasdaq
- NSPR Nasdaq
- Market Cap
- STHO 113.4M
- NSPR 101.8M
- IPO Year
- STHO N/A
- NSPR N/A
- Fundamental
- Price
- STHO $8.74
- NSPR $2.40
- Analyst Decision
- STHO
- NSPR Strong Buy
- Analyst Count
- STHO 0
- NSPR 2
- Target Price
- STHO N/A
- NSPR $4.50
- AVG Volume (30 Days)
- STHO 50.2K
- NSPR 86.7K
- Earning Date
- STHO 11-04-2025
- NSPR 08-05-2025
- Dividend Yield
- STHO N/A
- NSPR N/A
- EPS Growth
- STHO N/A
- NSPR N/A
- EPS
- STHO N/A
- NSPR N/A
- Revenue
- STHO $113,989,000.00
- NSPR $7,066,000.00
- Revenue This Year
- STHO N/A
- NSPR $7.48
- Revenue Next Year
- STHO N/A
- NSPR $104.39
- P/E Ratio
- STHO N/A
- NSPR N/A
- Revenue Growth
- STHO N/A
- NSPR 7.60
- 52 Week Low
- STHO $6.06
- NSPR $1.99
- 52 Week High
- STHO $14.50
- NSPR $3.80
- Technical
- Relative Strength Index (RSI)
- STHO 68.36
- NSPR 45.83
- Support Level
- STHO $8.39
- NSPR $2.36
- Resistance Level
- STHO $8.77
- NSPR $2.51
- Average True Range (ATR)
- STHO 0.25
- NSPR 0.09
- MACD
- STHO 0.03
- NSPR -0.00
- Stochastic Oscillator
- STHO 85.53
- NSPR 35.29
About STHO Star Holdings Shares of Beneficial Interest
Star Holdings engages in non-ground lease-related businesses, including real estate finance, operating properties, and land and development. Its portfolio is comprised of its interests in Asbury and Magnolia Green residential development projects, a portfolio of commercial real estate properties, and loans that are being marketed for sale. The Company operates its business through one reportable and operating segment that focuses on realizing value for shareholders by generating cash flows through active asset management and sales of its existing loans, operating properties and land and development properties.
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.